UFP Technologies, Inc. Cost of Revenue
UFP Technologies, Inc. (UFPT) reported Cost of Revenue of $123.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- UFP Technologies, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $123.05M, a 14.32% increase year-over-year.
- UFP Technologies, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $109.84M, a 3.63% increase year-over-year.
- UFP Technologies, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $106.95M, a 4.84% increase year-over-year.
- UFP Technologies, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $111.81M, a 7.88% increase year-over-year.
- UFP Technologies, Inc. cost of goods and services sold for fiscal 2025 was $432.39M, a 20.87% increase from fiscal 2024.
- UFP Technologies, Inc. cost of goods and services sold for fiscal 2024 was $357.73M, a 24.28% increase from fiscal 2023.
- UFP Technologies, Inc. cost of goods and services sold for fiscal 2023 was $287.85M, a 9.23% increase from fiscal 2022.
- UFP Technologies, Inc. cost of goods and services sold for fiscal 2022 was $263.53M, a 69.79% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $123.05M 10-Q · filed 2026-08-06 | $232.89M 10-Q · filed 2026-08-06 | $339.83M derived: sum of 3 quarters · filed 2026-08-06 | $451.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $109.84M 10-Q · filed 2026-05-08 | $216.79M derived: sum of 2 quarters · filed 2026-05-08 | $328.60M derived: sum of 3 quarters · filed 2026-05-08 | $436.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $106.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $218.76M derived: sum of 2 quarters · filed 2026-02-27 | $326.39M derived: sum of 3 quarters · filed 2026-08-06 | $432.39M 10-K · filed 2026-02-27 |
| 2025-09-30 | $111.81M 10-Q · filed 2025-11-07 | $219.44M derived: sum of 2 quarters · filed 2026-08-06 | $325.44M 10-Q · filed 2025-11-07 | $427.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $107.63M 10-Q · filed 2026-08-06 | $213.63M 10-Q · filed 2026-08-06 | $315.64M derived: sum of 3 quarters · filed 2026-08-06 | $419.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $106.00M 10-Q · filed 2026-05-08 | $208.01M derived: sum of 2 quarters · filed 2026-05-08 | $311.65M derived: sum of 3 quarters · filed 2026-05-08 | $388.80M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $102.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $205.66M derived: sum of 2 quarters · filed 2026-02-27 | $282.80M derived: sum of 3 quarters · filed 2026-02-27 | $357.73M 10-K · filed 2026-02-27 |
| 2024-09-30 | $103.64M 10-Q · filed 2025-11-07 | $180.79M derived: sum of 2 quarters · filed 2025-11-07 | $255.71M 10-Q · filed 2025-11-07 | $331.08M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $77.15M 10-Q · filed 2025-08-11 | $152.07M 10-Q · filed 2025-08-11 | $227.44M derived: sum of 3 quarters · filed 2026-02-27 | $300.47M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $74.93M 10-Q · filed 2025-05-12 | $150.29M derived: sum of 2 quarters · filed 2026-02-27 | $223.33M derived: sum of 3 quarters · filed 2026-02-27 | $293.72M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $75.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $148.40M derived: sum of 2 quarters · filed 2026-02-27 | $218.79M derived: sum of 3 quarters · filed 2026-02-27 | $287.85M 10-K · filed 2026-02-27 |
| 2023-09-30 | $73.03M 10-Q · filed 2024-11-12 | $143.43M derived: sum of 2 quarters · filed 2024-11-12 | $212.48M 10-Q · filed 2024-11-12 | $280.44M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $70.39M 10-Q · filed 2024-08-09 | $139.44M 10-Q · filed 2024-08-09 | $207.40M derived: sum of 3 quarters · filed 2025-03-03 | $278.85M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $69.05M 10-Q · filed 2024-05-10 | $137.01M derived: sum of 2 quarters · filed 2025-03-03 | $208.46M derived: sum of 3 quarters · filed 2025-03-03 | $278.48M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $67.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $139.40M derived: sum of 2 quarters · filed 2025-03-03 | $209.42M derived: sum of 3 quarters · filed 2025-03-03 | $263.53M 10-K · filed 2025-03-03 |
| 2022-09-30 | $71.45M 10-Q · filed 2023-11-09 | $141.47M derived: sum of 2 quarters · filed 2023-11-09 | $195.57M 10-Q · filed 2023-11-09 | $238.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $70.02M 10-Q · filed 2023-08-09 | $124.13M 10-Q · filed 2023-08-09 | $167.40M derived: sum of 3 quarters · filed 2024-02-29 | $206.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $54.11M 10-Q · filed 2023-05-10 | $97.38M derived: sum of 2 quarters · filed 2024-02-29 | $136.08M derived: sum of 3 quarters · filed 2024-02-29 | $173.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $43.27M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29 | $81.97M derived: sum of 2 quarters · filed 2024-02-29 | $119.22M derived: sum of 3 quarters · filed 2024-02-29 | $155.21M 10-K · filed 2024-02-29 |
| 2021-09-30 | $38.71M 10-Q/A · filed 2022-11-14 | $75.95M derived: sum of 2 quarters · filed 2022-11-14 | $111.94M 10-Q/A · filed 2022-11-14 | $145.71M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $37.24M 10-Q · filed 2022-08-09 | $73.23M 10-Q · filed 2022-08-09 | $107.00M derived: sum of 3 quarters · filed 2023-03-16 | $139.77M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $35.99M 10-Q · filed 2022-05-10 | $69.76M derived: sum of 2 quarters · filed 2023-03-16 | $102.53M derived: sum of 3 quarters · filed 2023-03-16 | $135.23M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $33.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $66.54M derived: sum of 2 quarters · filed 2023-03-16 | $99.24M derived: sum of 3 quarters · filed 2023-03-16 | $134.69M 10-K · filed 2023-03-16 |
| 2020-09-30 | $32.77M 10-Q · filed 2021-11-05 | $65.47M derived: sum of 2 quarters · filed 2021-11-05 | $100.92M 10-Q · filed 2021-11-05 | $137.41M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-06-30 | $32.70M 10-Q · filed 2021-08-06 | $68.15M 10-Q · filed 2021-08-06 | $104.64M derived: sum of 3 quarters · filed 2022-03-14 | $140.71M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | $35.45M 10-Q · filed 2021-05-07 | $71.94M derived: sum of 2 quarters · filed 2022-03-14 | $108.02M derived: sum of 3 quarters · filed 2022-03-14 | $145.04M derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | $36.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $72.56M derived: sum of 2 quarters · filed 2022-03-14 | $109.59M derived: sum of 3 quarters · filed 2022-03-14 | $144.42M 10-K · filed 2022-03-14 |
| 2019-09-30 | $36.07M 10-Q · filed 2020-11-06 | $73.10M derived: sum of 2 quarters · filed 2020-11-06 | $107.93M 10-Q · filed 2020-11-06 | $145.92M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $37.03M 10-Q · filed 2020-08-07 | $71.86M 10-Q · filed 2020-08-07 | $109.85M derived: sum of 3 quarters · filed 2021-03-12 | $145.23M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $34.83M 10-Q · filed 2020-05-08 | $72.82M derived: sum of 2 quarters · filed 2021-03-12 | $108.20M derived: sum of 3 quarters · filed 2021-03-12 | $144.23M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $37.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $73.37M derived: sum of 2 quarters · filed 2021-03-12 | $109.40M derived: sum of 3 quarters · filed 2021-03-12 | $142.15M 10-K · filed 2021-03-12 |
| 2018-09-30 | $35.38M 10-Q · filed 2019-11-08 | $71.41M derived: sum of 2 quarters · filed 2019-11-08 | $104.16M 10-Q · filed 2019-11-08 | $133.54M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $36.03M 10-Q · filed 2019-08-09 | $68.78M 10-Q · filed 2019-08-09 | $98.16M derived: sum of 3 quarters · filed 2020-03-13 | $125.65M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $32.75M 10-Q · filed 2019-05-10 | $62.13M derived: sum of 2 quarters · filed 2020-03-13 | $89.62M derived: sum of 3 quarters · filed 2020-03-13 | $117.56M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $29.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $56.87M derived: sum of 2 quarters · filed 2020-03-13 | $84.82M derived: sum of 3 quarters · filed 2020-03-13 | $112.36M 10-K · filed 2020-03-13 |
| 2017-09-30 | $27.49M 10-Q · filed 2018-11-09 | $55.44M derived: sum of 2 quarters · filed 2018-11-09 | $82.97M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $27.95M 10-Q · filed 2018-08-09 | $55.48M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $27.54M 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $111.48M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |